Phytoplenus is a private Brazilian corporation which has an industrial unit located in the city of Pinhais, metropolitan region of Curitiba/Paraná, South of Brazil. It is equipped with an advanced and innovative technological production and quality control of pharmaceutical ingredients structure, which is duly approved by ANVISA (Agência Nacional de Vigilância Sanitária – National Sanitary Control Agency) and was designed to meet the highest standards of the pharmaceutical industry.
The Phytoplenus arose as a result of a technology that combined the extraction and the generation of complex molecular structures based on bioactive compounds of medicinal plants of the global and the Brazilian biodiversity, making the most of the therapeutic properties of these bioactive compounds. The studies that led to this technology were a result of more than seven years of scientific researches and preclinical and clinical studies.
This efficient plant extraction process allows the production of special pharmaceutical ingredients that ought to be used topically on the injured skin. Differently from the hydrocellular / hydrocolloid gel dressings, which are expensive and complex for wound management, Phytoplenus products are inexpensive and very easy to apply on the affected area. In general, the results from the administration of these phytomedicines on the wounds showed a substantial reduction of the healing time, relief of the pain on the affected area and minor formation of fibrous scar tissue. Moreover, other properties or these medicinal plants, such as antibacterial and bacteriostatic activities, were observed. Many professionals, including doctors, veterinarians and nurses who use the phytomedicines produced by this process were greatly impressed by the results obtained, especially in clinical cases of extreme difficult healing processes.
The product strategy of Phytoplenus Technology based on the significant number of pharmaceutical, cosmeceutical and veterinary products that can be developed from this technology was the groundwork of this company.
Phytoplenus was founded as formal legal entity on March 1, 2009, even though it has existed since 2003 as a research and business planning joint venture. It has been made a corporation on August 18, 2010.
The mission of Phytoplenus Bioativos S.A. is the development and the production of high quality phytochemical ingredients based on natural bioactive compounds, which are produced through an innovative extraction technology to promote the health and the well-being of users of its products as essential tools to the community of health professionals and a support tool for the hospital and health insurance managers.
Phytoplenus will be recognized as the best phytochemical industry that produces high quality natural bioactive compounds, becoming the international leader of this segment, not only because of its sales amount, but also because it is the most recognized and desired brand.
Developing and producing pharmaceutical bioactive ingredients with high quality and efficiency, seeking continuous improvement of the processes through innovative technologies, providing excellent therapeutic results and life quality for the end-users.
